The relatively high frequency of sequence variations in TALDO1 also indicate that most nucleotide changes may only have moderate effects on enzymatic activity without clinical consequences unless exposed to severe metabolic stress, as noted in four APAP‐induced liver failure patients. This evidence concerns the gene TALDO1 and Hepatic failure.